Purchase Order 36C26322P0780

Award Date 7/18/22
Potential Completion Date 1/23/23
Potential Value $96K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North River, ND 58102, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm fixed-price delivery order is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's mission of...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract has a firm fixed price and an ultimate...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is a delivery order under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022 with a ceiling value of $28.85 million. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields...
This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune Plus rental equipment and associated support services for the treatment of glioblastoma and mesothelioma in veteran patients. The contract was awarded under Novocure's existing 5-year Federal Supply Schedule (FSS)...
This federal contract award, valued at $99,497.46, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This award is a delivery order under Novocure's 5-year Federal Supply Schedule (FSS)...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a delivery order under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices,...

This federal contract award, valued at $96,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services for a 6-month period. The contract is a firm fixed-price purchase order and does not utilize any set-aside designations.

Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at up to $28.85 million, which provides a streamlined procurement vehicle for the VA to obtain Novocure's innovative cancer treatment technologies for distribution to VA medical centers nationwide. This specific contract award supports the VA's mission of expanding veterans' access to cutting-edge cancer therapies by enabling VA facilities to offer Novocure's non-invasive TTFields treatment option to veteran patients diagnosed with glioblastoma, mesothelioma, and other forms of solid tumor cancers.

Generated 4/2/25, 4:18 PM